Home Page > Hearing - 110th Congress

HEARING

The Adequacy of FDA to Assure the Safety of the Drug Supply

Subcommittee on Oversight and Investigations
"The Adequacy of FDA Efforts to Assure the Safety of the Drug Supply"
Tuesday, February 13, 2007, 9:15 a.m.
2123 Rayburn House Office Building

Hearing Webcast

(Any use of this recording is subject to Rule XI, 4 of the House of Representatives. See text of Rule XI, 4 as posted by the House Committee on Rules.)

Connect to the Archived Video Webcast of this hearing (100 kbps) or Download

Windows Media Player is required for Committee Webcasts.

Witness List & Prepared Testimony (pdf files)

Panel I
The Honorable Chuck Grassley United States Senate 135 Hart Senate Office Building Washington, D.C. 20510
Panel II
David B. Ross, M.D., Ph.D. National Clinical Public Health Program U.S. Department of Veterans Affairs	John H. Powers, III M.D., FACP FIDSA Scientific Applications International Corporation
Ann Marie Cisneros Independent Clinical Research Associate
Panel III
Steven E. Nissen M.D., FACC Chairman, Department of Cardiovascular Medicine Cleveland Clinic Foundation 9500 Euclid Avenue Cleveland, OH 44195	David J. Graham, M.D., MPH Associate Director for Science and Medicine Office of Surveillance and Epidemiology Food and Drug Administration

Printed Hearing

Serial No. 110-5 -- The Adequacy of FDA to Assure the Safety of the Nation's Drug Supply, February 13, 2007
TEXT (580K) | PDF (7.4M)

(The text and pdf transcript links direct you to the Government Printing Office Access Web site at http://www.access.gpo.gov/congress/house/house05ch110.html)